Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 27 registrations
- Tri-Cira 210.035 MG + 0.035 MG + 0.035 MG + 0.215 MG + 0.25 MG + 0.18 MG · Tablet · Apotex INC
- Tri-Cira 280.035 MG + 0.035 MG + 0.035 MG + 0.18 MG + 0.25 MG + 0.215 MG · Tablet · Apotex INC
- Tri-Cira Lo 210.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.25 MG + 0.18 MG · Tablet · Apotex INC
- Tri-Cira Lo 280.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.18 MG + 0.25 MG · Tablet · Apotex INC
United States
FDA · 24 registrations
- Estarylla0.035MG; 0.25MG · tablet · Xiromed
- Mili0.035MG; 0.25MG · tablet · Aurobindo Pharma LTD
- Mono-Linyah0.035MG; 0.25MG · tablet · Novast Labs LTD
- Norgestimate and Ethinyl Estradiol0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG, 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG, 0.035MG; 0.25MG · tablet · Lupin
Spain
AEMPS · 3 registrations
At a glance
- Registers
- 6
- Historical lists
- 1
- Registrations
- 59
- With their own page
- 31
- Companies
- 24
All medicines with Norgestimate
Human medicines from every register that match Norgestimate by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
61 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Norgestimate; Ethinyl EstradiolCombination | United States | 0.215MG; 0.025MG, 0.215MG; 0.035MG, 0.25MG; 0.025MG … | tablet | Marketed | Glenmark Pharms LTD |
| Norgestimate and Ethinyl EstradiolCombination | United States | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG, 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG, 0.035MG; 0.25MG | tablet | Marketed | Lupin |
| Norgestimaat/Ethinylestradiol Xiromed 0,25 mg/0,035 mg tablettenCombination | Netherlands | Tablet | Authorised | Medical Valley Invest AB | |
| EstaryllaCombination | United States | 0.035MG; 0.25MG | tablet | Marketed | Xiromed |
| Tri-EstaryllaCombination | United States | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Marketed | Xiromed |
| Tri-Lo-EstaryllaCombination | United States | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Marketed | Xiromed |
| Estradiol and NorgestimateCombination | United States | 1MG,1MG; 0.09MG | tablet | Not marketed | Barr |
| MiliCombination | United States | 0.035MG; 0.25MG | tablet | Marketed | Aurobindo Pharma LTD |
| Mono-LinyahCombination | United States | 0.035MG; 0.25MG | tablet | Marketed | Novast Labs LTD |
| SprintecCombination | United States | 0.035MG; 0.25MG | tablet | Marketed | Barr |
| Tri-LinyahCombination | United States | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Marketed | Novast Labs LTD |
| Tri-Lo-MiliCombination | United States | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Marketed | Aurobindo Pharma |
| Tri Lo SprintecCombination | United States | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Marketed | Barr Labs INC |
| Tri-MiliCombination | United States | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Marketed | Aurobindo Pharma LTD |
| Tri-SprintecCombination | United States | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Marketed | Barr |
| Edelsine 0,250/0,035 MG ComprimidosCombination | Spain | 0,250 mg + 0,035 mg | comprimido | Marketed | Laboratorios Effik S.A. |
| Ortho Tri-Cyclen 21Combination | United States | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Marketed | Ortho Mcneil Pharm |
| Ortho Tri-Cyclen 28Combination | United States | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Marketed | Ortho Mcneil Pharm |
| Tri-Lo-LinyahCombination | United States | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Marketed | Novast Labs |
| Tri-Cira 21Combination | Canada | 0.035 MG + 0.035 MG + 0.035 MG + 0.215 MG + 0.25 MG + 0.18 MG | Tablet | Marketed | Apotex INC |
| Tri-Cira 28Combination | Canada | 0.035 MG + 0.035 MG + 0.035 MG + 0.18 MG + 0.25 MG + 0.215 MG | Tablet | Marketed | Apotex INC |
| Tri-Cira Lo 21Combination | Canada | 0.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.25 MG + 0.18 MG | Tablet | Marketed | Apotex INC |
| Tri-Cira Lo 28Combination | Canada | 0.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.18 MG + 0.25 MG | Tablet | Marketed | Apotex INC |
| Tri-Jordyna 21Combination | Canada | 0.035 MG + 0.035 MG + 0.035 MG + 0.18 MG + 0.25 MG + 0.215 MG | Tablet | Marketed | Glenmark Pharmaceuticals Canada INC. |
| Tri-Jordyna 28Combination | Canada | 0.035 MG + 0.035 MG + 0.035 MG + 0.18 MG + 0.25 MG + 0.215 MG | Tablet | Marketed | Glenmark Pharmaceuticals Canada INC. |